Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Inflammatory Bowel Diseases

Treatments: Drug: Indigo Carmine

Study type: Interventional

Funder types: Other

Identifiers

NCT01914445

HYMC-46-13

Details and patient eligibility

About

The purpose of this study is to examine whether oral administration of Indigo Carmine together with Polyethylene Glycol (PEG), the usual colon preparatory solution, can be used instead of staining during the examination itself.

Enrollment: 10 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients suffering from Inflammatory Bowel Disease
• Patients under surveillance for Disease-Associated Lesions and Masses (DALM)

Exclusion criteria

• All others

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Indigo Carmine

Experimental group

Description:

Indigo Carmine (2 mg per kilo) and 2nd half of PEG dose will be orally administered to patients prior to colonoscopy.

Treatment:

Drug: Indigo Carmine